We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-1.50 | -0.09% | 1,754.50 | 1,753.50 | 1,754.50 | 1,755.50 | 1,740.50 | 1,743.50 | 403,151 | 09:41:28 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.62 | 72.03B |
Date | Subject | Author | Discuss |
---|---|---|---|
06/2/2020 15:33 | Yes agree, hopefully see 2000p by the end of the year. | philanderer | |
06/2/2020 14:45 | Same reaction following the Tesaro deal This will settle down and gradually retrace but could take time !! | panshanger1 | |
06/2/2020 14:31 | 2020p by end of 2020 ... ;0) | tradermichael | |
06/2/2020 14:26 | Nasty hit since the announcement. Looks like it is mostly profit taking though, results weren't far enough off analysts expectations to give this 100+ point drop. I see this as a good hold for 2020 and if the 5+ expected approvals come through then I wouldn't put £19/20 out of the question. Beyond 2020 though the uncertainty over the break-up which will inevitably be delayed will likely impact the price. I also think that the early stage pipeline is very weak, to have a pipeline with a similar number of products in phase 1, 2, and 3 is very unbalanced. I expect this is why we have seen the extra injection into R&D, to bolster the Phase 1 pipeline in particular. I expect we will also see some more Tesaro's to bolster this. | milehouse | |
06/2/2020 13:51 | Looking forward to these getting back to their usual pattern of 1500 to 1620/40 for range trading, have earned a packet over these over last few years doing that and thought they would get a nosebleed above 17.50, they dont have the pipeline of big earning drugs, the split wont add add any value and is costing a fortune, free cash flow is desperate. They have been “ found out “. | porsche1945 | |
06/2/2020 13:41 | Not my buys - opened a small bullish position today. ;) | alphorn | |
06/2/2020 12:24 | But surprisingly with a buy of nearly18 million shares @17.26 pounds the share price never moved,what is happened to the order book? | abdullla | |
06/2/2020 11:58 | Yes TM another 5.7 million has gone through,could be short covering hedge fund who probably dropped the share price in the first place. | abdullla | |
06/2/2020 11:48 | A massive buy just came in at 1726p. This boosted the volume traded so far to 16 million+ | tradermichael | |
06/2/2020 10:18 | I am not sure that AZN would go for that now. That would indicate weaknesses as pure cost cutting. | alphorn | |
06/2/2020 10:15 | Or 2 Anglo-American companies? | tradermichael | |
06/2/2020 10:02 | As I said yesterday is the corporate activity out of weakness or strength? Some others are talking about doing the same. It may restart the idea of the 2 Swiss companies coming together? | alphorn | |
06/2/2020 09:52 | I was looking to sell the other day but held off thinking/wishing the results might be better than forecast. Silly me. Oh well...at least I share now the sentiment of this GSK thread....The Recovery! | waldo2020 | |
06/2/2020 09:48 | It happens - it happened in the UK in 1978 with smallpox | tradermichael | |
06/2/2020 09:45 | But rumour also has it that it was the Chinese who brought the virus into the country and accidentally broke the vial. | abdullla | |
06/2/2020 09:33 | so ignorant brextremist lippy4 is on this thread ! No wonder GSK is falling( joking ) . This stock likely to recover quite soon I think as fall overdone . | arja | |
06/2/2020 09:19 | You have moved forward 2 months in 10 minutes is the positive way to look at things. Rumours overnight that Chinese have discovered an antidote. | our haven | |
06/2/2020 09:09 | The one that successfully discovers the Coronavirus vaccine will indeed be the winner,will it be GSK? | abdullla | |
06/2/2020 09:00 | I came to this market to move forward not to where it was 4months ago. | abdullla | |
06/2/2020 08:41 | Let's not get too carried away, the price is only back to where it was 4 months ago | our haven | |
06/2/2020 08:40 | It would be a different outcome if Emma had accurately forecast the market size for Shingrix, especially as it takes so long to build a new plant to satisfy demand. That means technical as well as commercial incompetence. I hope she gets it right with the COPD vaccine. | tradermichael | |
06/2/2020 08:35 | It is worst than a profit warning. | abdullla | |
06/2/2020 08:32 | i thought the management were there to increase value not destroy it???? | lippy4 | |
06/2/2020 08:31 | this is painful.... | lippy4 | |
06/2/2020 08:31 | This has 14 quid written all over it. I am out | amt |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions